Details for Patent: 11,097,006
✉ Email this page to a colleague
Which drugs does patent 11,097,006 protect, and when does it expire?
Patent 11,097,006 protects ARISTADA and is included in one NDA.
This patent has fourteen patent family members in eight countries.
Summary for Patent: 11,097,006
Title: | Pharmaceutical compositions having improved storage stability |
Abstract: | The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent |
Inventor(s): | Perry; Jason M. (Cambridge, MA), Deaver; Daniel R. (Franklin, MA), Hickey; Magali B. (Westwood, MA), Remenar; Julius F. (Framingham, MA), Vandiver; Jennifer (Arlington, MA), Palmieri, Jr.; Michael J. (Hopkington, MA), Pan; Zhengzheng (Arlington, MA) |
Assignee: | ALKERMES PHARMA IRELAND LIMITED (Waltham, MA) |
Application Number: | 16/834,565 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 11,097,006
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-001 | Oct 5, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | |||
Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-002 | Oct 5, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | |||
Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-003 | Oct 5, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | |||
Alkermes Inc | ARISTADA | aripiprazole lauroxil | SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 207533-004 | Jun 5, 2017 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,097,006
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013349388 | ⤷ Sign Up | |||
Canada | 2885196 | ⤷ Sign Up | |||
European Patent Office | 2897592 | ⤷ Sign Up | |||
European Patent Office | 3718536 | ⤷ Sign Up | |||
Spain | 2792149 | ⤷ Sign Up | |||
Hong Kong | 1210033 | ⤷ Sign Up | |||
Japan | 2015529237 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |